- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05708833
Intra-Osseous Access in Difficult Vascular Access Cases (IODA)
Thousands of peripheral venous accesses are inserted every day all over the world. Some of them, such as those inserted in emergency and / or in critical patients, are absolutely vital. In the particular context of prehospital care, the rate of failure of the first attempt to insert a peripheral venous access has been evaluated at 25%. Success rates of successive attempts were about 75%. Nevertheless, the final success rate is close to 100%.
Failure or delay in obtaining venous access can be life-threatening. Thus, alternatives to peripheral venous access have been proposed including intraosseous route recently made easier by the development of an automated puncture device (EZ-IO®), but still rarely used, especially on conscious patient.
Currently, the place of intraosseous venous access in critical patients is not determined.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bobigny, France, 93000
- Hôpital Avicenne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patient, in prehospital setting, without venous access and after failure of the first attempt to place a peripheral venous access by a senior operator (doctor or nurse) AND
Patient with hemodynamic failure defined as:
- systolic blood pressure (SBP) < 90 mm Hg (2 measures) or
- cardiac arrest or
- Any situation requiring intubation
Exclusion Criteria:
1- Age < 18 years
2- Venous access already available
3- Known contra-indications to intraosseous access (i.e. bilateral lesions):
- Bone fracture
- Skin infection
- Osteoporosis
- Osteomyelitis
- Local burns
- Recent failed intraosseous attempt
- Prior surgery
- Compartment syndrome
Every other local specific situations
4- Pregnancy woman
5- Patient with no national health or universal plan affiliation coverage
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intraosseous venous access
|
Immediate placement of humeral intra-osseous venous access (after a first failed attempt of peripheral venous access)
|
|
Active Comparator: peripheral venous access
Limiting use of intraosseous access (intraosseous access possible after 3 attempts of peripheral venous access)
|
Looking for peripheral venous access, changing the site of puncture, the caliber of the catheter and/or the operator and/or assistance tools (ultrasound, infra-red guidance...) and/or using another route (oral, rectal, subcutaneous, intramuscular route and central venous access)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To demonstrate that the early recourse to the intraosseous route, from the first failure, makes it possible to obtain more quickly the correction of the failure of critical patient managed in prehospital setting.
Time Frame: • In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
• In patients with cardiac arrest: Time required for a return of spontaneous circulation (ROSC). Only the first ROSC will be considered. |
• In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
|
To demonstrate that the early recourse to the intraosseous route, from the first failure, makes it possible to obtain more quickly the correction of the failure of critical patient managed in prehospital setting.
Time Frame: • In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
• In patients with hemodynamic failure: delay to reach a systolic blood pressure correction, i.e. systolic blood pressure > 90 mm Hg. Systolic blood pressure will be assessed every 5 minutes after the placement of the intravenous line. Two consecutive measures are required to reach the end-point. In the cases where continuous invasive blood pressure monitoring will be available, systolic blood pressure > 90 mm Hg > 1 minute will be required. |
• In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
|
To demonstrate that the early recourse to the intraosseous route, from the first failure, makes it possible to obtain more quickly the correction of the failure of critical patient managed in prehospital setting.
Time Frame: • In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
|
• In patients requiring endo-tracheal intubation: time required to achieve intubation.
|
• In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: 1 minute
|
Failure to place the catheter defined by the absence of infusion or by withdrawal of the catheter within one minute after the opening of the infusion
|
1 minute
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
Number of punctures
|
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
Number of punctures
|
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
|
Number of sites treated
|
In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC). In patients with hemodynamic failure: Reach a systolic blood pressure correction. In patients requiring endo-tracheal intubation: Achieve intubation
|
Use of alternative routes (central venous access, oral, rectal, subcutaneous, intramuscular - and intra-osseous in the control group)
|
In patients with cardiac arrest: Return of spontaneous circulation (ROSC). In patients with hemodynamic failure: Reach a systolic blood pressure correction. In patients requiring endo-tracheal intubation: Achieve intubation
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
Use of alternative routes (central venous access, oral, rectal, subcutaneous, intramuscular - and intra-osseous in the control group)
|
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
Use of alternative routes (central venous access, oral, rectal, subcutaneous, intramuscular - and intra-osseous in the control group)
|
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
|
Use of assistance tools (ultrasound, infra-red)
|
In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC). In patients with hemodynamic failure: Reach a systolic blood pressure correction. In patients requiring endo-tracheal intubation: Achieve intubation
|
Delays in placing venous access
|
In patients with cardiac arrest: Return of spontaneous circulation (ROSC). In patients with hemodynamic failure: Reach a systolic blood pressure correction. In patients requiring endo-tracheal intubation: Achieve intubation
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
Delays in placing venous access
|
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
Delays in placing venous access
|
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
Delays for administration of drugs/solutes
|
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
Delays for administration of drugs/solutes
|
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
|
To characterize the conditions for implementation of the procedure, depending on the strategy used.
Time Frame: In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
|
Delays for administration of drugs/solutes
|
In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour
|
|
To determine the length of stay in hospital
Time Frame: Days 28
|
Length of stay in hospital
|
Days 28
|
|
To evaluate morbidity depending on the strategy used.
Time Frame: In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
Non-functional venous
|
In patients with cardiac arrest: Return of spontaneous circulation (ROSC), an average of 1 hour
|
|
To evaluate morbidity depending on the strategy used.
Time Frame: In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
Non-functional venous
|
In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
|
To evaluate morbidity depending on the strategy used.
Time Frame: IIn patients requiring endo-tracheal intubation: Achieve intubation, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
Non-functional venous
|
IIn patients requiring endo-tracheal intubation: Achieve intubation, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
|
To evaluate morbidity depending on the strategy used.
Time Frame: Days 28
|
Local complication (subcutaneous diffusion, hematoma, pain...)
|
Days 28
|
|
To evaluate morbidity depending on the strategy used.
Time Frame: Hours 72
|
Need to replace the venous access
|
Hours 72
|
|
To evaluate mortality depending on the strategy used.
Time Frame: Days 28
|
Death
|
Days 28
|
|
To evaluate the patient's feedback, depending on the strategy used.
Time Frame: Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
Evaluation of procedural pain on an analog visual scale, EVA, simple verbal scale, EVS or numerical scale, EN (from 0 to 100, the higher is the worse) In the case of patient with cardiac arrest, only the operator satisfaction will be assessed.
|
Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
|
To evaluate the team's feedback, depending on the strategy used.
Time Frame: Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
Operator satisfaction assessed (EVA, EVS or EN) after the placement of the catheter and on arrival at the hospital (from 0 to 100, the higher is the worse).
|
Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour
|
Collaborators and Investigators
Investigators
- Principal Investigator: LAPOSTOLLE Frédéric, PhD MD, APHP
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- P170918J
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodynamic Instability
-
Hitit UniversityRecruitingHemodynamic InstabilityTurkey (Türkiye)
-
Kanuni Sultan Suleyman Training and Research HospitalRecruitingHemodynamic InstabilityTurkey
-
Johannes Gutenberg University MainzRecruiting
-
Johannes Gutenberg University MainzRecruitingHemodynamic InstabilityGermany
-
Chaudhry Pervaiz Elahi Institute of CardiologyRecruitingHemodynamic InstabilityPakistan
-
Cairo UniversityCompletedHemodynamic InstabilityEgypt
-
University of MonastirCompleted
-
Mansoura UniversityCompleted
-
University of British ColumbiaCompletedHemodynamic InstabilityCanada
Clinical Trials on Intraosseous venous access
-
Lars Wiuff AndersenUniversity of Aarhus; Central Denmark RegionActive, not recruiting
-
Lazarski UniversityPoznan University of Medical Sciences; Wroclaw Medical University; Medical University...CompletedEmergencies | Cardiac ArrestPoland
-
Vidacare CorporationCompletedVascular AccessUnited States
-
Vidacare CorporationUnknownIntraosseous Access | Infusion Rates | Intraosseous Blood | Venous BloodUnited States
-
Vidacare CorporationCompletedVascular Access | Intraosseous Vascular AccessUnited States
-
University Hospital of PatrasCompletedPacemaker | Implantable Cardioverter-defibrillatorGreece
-
Lazarski UniversityPoznan University of Medical Sciences; Wroclaw Medical University; Medical University...CompletedShock | Emergency Medicine | Cardiopulmonary ArrestPoland
-
Vidacare CorporationCompletedPatients Requiring Urgent Vascular AccessUnited States
-
University Hospital of FerraraCompletedArrhythmias, Cardiac | Implantable Defibrillator User | Vascular Access Complication | Venous Puncture | Pacemaker Complication | Fluoroscopy; Adverse EffectItaly
-
E-DA HospitalUnknownTime to Insertion | Rates of ComplicationsTaiwan